Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trial

Introduction Atherosclerotic cardiovascular disease (ASCVD) continues to be a leading cause of preventable death globally. Polygenic risk scores (PRS) offer a way to detect individuals at higher relative risk of developing ASCVD, but they have not yet been incorporated into routine clinical practice...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Krista Fischer, Mikk Jürisson, Lili Milani, Karolin Toompere, Alar Irs, Ruth Kalda, Katrin Kaarna, Ave Voit, Aet Elken, Margus Viigimaa, Helene Alavere, Sander Pajusalu, Elin Org, Janika Alloja
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 2026-05-01
Serija:	BMJ Open
Online dostop:	https://bmjopen.bmj.com/content/16/5/e120048.full
Oznake:	Označite Brez oznak, prvi označite!